Merus Announces Re-Election of Directors

TORONTO, March 21, 2017 /CNW/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] reported today the results of its 2017 annual general and special meeting of shareholders held on March 21, 2017.

All directors nominated, as listed in the Company's management information circular dated February 15, 2017 (the "Information Circular"), were re-elected as members of the board as follows:

Director

Votes For(*)

% For

Withheld Votes(*)

%

Michael Cloutier

55,014,419

99.70%

165,368

0.30%

Robert S. Pollock

55,006,380

99.69%

173,407

0.31%

Timothy G. Sorensen

54,994,235

99.66%

185,552

0.34%

David D. Guebert

55,018,949

99.71%

160,838

0.29%

Theresa Firestone

55,018,300

99.71%

161,487

0.29%

Barry Fishman

55,014,516

99.70%

165,271

0.30%

Robert Bloch

55,001,680

99.68%

178,107

0.32%

(*)   Reflects votes represented by proxy

In addition, shareholders of the Company approved:

  • the appointment of MNP LLP, Chartered Accountants, as the auditor of Merus to hold office until the next annual meeting of shareholders,
  • the amendments to the Company's stock option plan announced on March 13, 2017,
  • the continuation of the Company's stock option plan for an additional three year term, and
  • the amendments to the Company's articles, as described in the Information Circular, by special resolution.

About Merus Labs

Merus Labs is a specialty pharmaceutical company focused on acquiring and optimizing established and growth products. The Company leverages its expertise and commercial platform in Europe, Canada and select other markets to deliver value.

SOURCE Merus Labs Inc.

For further information: Phone: (905) 726-0995, Email: info@meruslabs.com, Website: www.meruslabs.com

RELATED LINKS
www.meruslabs.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890